Clinical Trials Browser

Not yet recruiting × Uterine Cervical Neoplasms × lenvatinib × Clear all

NCT07368985 2026-01-27

Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer

Phase 2 Not yet recruiting

Adenocarcinoma, Uterine Cervical Neoplasms